[HCB News] Faster, better, safer: The latest in PET and SPECT

June, 2022  By Lisa Chamoff

Manufacturers in the PET and SPECT space are focusing on decreasing scan times, improving image quality to see smaller irregularities and lowering ra-diation dose.
In nuclear medicine, product develop-ment has also focused on researching new radiotracers. There are also several preclinical devices in the research stages. Here’s a look at what’s new and what’s to come in the future.

DOSIsoft has been marketing its PLANET Onco Dose software for molecular imag-ing and molecular radiotherapy to provide patient-specific dosimetry, personalization of treatment and disease follow-up. The company has approval to use the software for SIRT/Yttrium-90 in the U.S., and is adding Lutetium-177 and Iodine-131 sup-port in both the U.S. and Europe.
The software is unique in that it’s multi-ra-dionuclides and vendor-neutral, said Sébas-tien Vauclin, product manager at DOSIsoft. “We wanted to have a complete solution that is independent of imaging manufactur-ers,” Vauclin said.

HCBN – June 2022 (dotmed.com)